Our products and services provide expert dosimetry analysis accompanied by the advice needed to address regulatory requirements, design appropriate imaging protocols, select patients mostly likely to respond, reduce toxicities to normal organs, and optimize patient outcomes.
Who We Are
We are focused on providing state-of-the art quantitative imaging and dosimetry services and products for developers and providers of radiopharmaceutical therapies.
Precision RPT is enabled by Rapid’s absorbed-dose calculations software
Service Number One
Absorbed-dose calculations accompanied by error bars improve confidence in dosimetry calculations
Service Number Two
Founders are innovators and academic thought-leaders in this field
Absorbed-dose calculations can accommodate alpha and beta emitter RPT
Service Number Three
Service Number Four
Uniting External Beam Radiation Therapy (XRT) and Radiopharmaceutical Therapy (RPT)
SPECT/CT or PET/CT images of RPT distribution used to estimate the spatial distribution of absorbed dose
Service Number Five
Our team is comprised of leading industry experts with extensive experience
We understand the importance of collaboration in our industry and work closely with partners to help achieve our mission of developing innovative technology.
If you are interested in partnering with us, we want to hear from you.
Our next-generation dosimetry & radiopharmaceutical technology has been recognized by many prestigious organizations and we have received numerous awards and grants including:
SBIR Grant & Supplement
Development and Validation of a Collaborative Web-Based Quantitative Imaging and Dosimetry System for Radiopharmaceutical Therapy
Software for Optimal Combination of External Beam Radiotherapy (XRT) and Radiopharmaceutical Therapy (RPT)
Quantitative SPECT of Difficult to Image Therapeutic Radionuclides: An Extensible Cloud-Based Framework
Treatment optimization by combined α-emitter (αRPT)/radiotherapy (XRT) dosimetry for prostate cancer patients.
Cloud/Subscription based, Customer-Responsive Dosimetry Tool for alpha-Particle Emitters
Targeted Radionuclide Therapy of Metastatic Liver Cancer: Patient Specific Optimization